Kidney Disease: Three Studies At-a-Glance
November 8, 2019
Highlighted: Chronic kidney disease and stroke risk, syphilis in ESRD patients, and how healthy diets may reduce CKD incidence.
Andrew D. Bowser
Autosomal-dominant Polycystic Kidney Disease: 3 Studies in Brief
July 7, 2019
Three new studies on ADPKD treatment project long-term impact of tolvaptan; reveal potential in an existing drug class; and, report success in slowing comorbid hepatic disease.
For ADPKD in Children, New Guidelines Speak to Ethical Issues
July 3, 2019
Most children with ADPKD remain asymptomatic, but some manifest early and aggressive disease. Try our 6 questions on the new expert guidance on tricky treatment issues.
Polycystic Kidney Disease: What's Your ADPKD IQ?
May 6, 2019
Autosomal dominant polycystic kidney disease is the most common form of polycystic renal disease. Find out what you know about ADPKD with this 7-question quiz on epidemiology, diagnosis, and more.
Chronic Kidney Disease: 7 Questions for Primary Care
March 7, 2019
The primary care role in detection, management, and reducing the risk of progression of CKD continues to expand. Test yourself here on basics in each category.
Loop Diuretics During Dialysis Reduce Hospitalization, Hypotension, Weight Gain
March 6, 2019
Keeping a loop diuretic on board during dialysis could be an effective, low-cost option to help improve patient outcomes, according to a new study.
5 Qs on Managing Hepatitis C in the Young
October 16, 2018
How much do you know about HCV treatment in children and teens? Take this short, 5-question quiz to find out.
HCV in Young Adults and Children: 3 Studies At-a-Glance
October 1, 2018
Study summaries highlight increased infection rates in young adults; a spike in HCV in reproductive-aged women; and a potential new treatment for HCV in young children.
Hep C Quiz: 5 Questions on the News
August 16, 2018
ICYMI: HCV elimination success, SVR in blacks, transplant delisting, clearance after acute infection—catch up with a quiz.
Organ Transplant in the Direct-acting Antiviral Era
August 3, 2018
Can DAA therapy remove patients from transplant waiting lists? Are HCV-infected livers--and hearts--safe for uninfected organ recipients? Three new studies explain.
